Literature DB >> 28049083

Recovery assessment scale: Examining the factor structure of the German version (RAS-G) in people with schizophrenia spectrum disorders.

M Cavelti1, M Wirtz2, P Corrigan3, R Vauth4.   

Abstract

BACKGROUND: The recovery framework has found its way into local and national mental health services and policies around the world, especially in English speaking countries. To promote this process, it is necessary to assess personal recovery validly and reliably. The Recovery Assessment Scale (RAS) is the most established measure in recovery research. The aim of the current study is to examine the factor structure of the German version of the RAS (RAS-G).
METHODS: One hundred and fifty-six German-speaking clients with schizophrenia or schizoaffective disorder from a community mental health service completed the RAS-G plus measures of recovery attitudes, self-stigma, psychotic symptoms, depression, and functioning. A confirmatory factor analysis of the original 24-item RAS version was conducted to examine its factor structure, followed by reliability and validity testing of the extracted factors.
RESULTS: The CFA yielded five factors capturing 14 items which showed a substantial overlap with the original subscales Personal Confidence and Hope, Goal and Success Orientation, Willingness to Ask for Help, Reliance on Others, and No Domination by Symptoms. The factors demonstrated mean to excellent reliability (0.59-0.89) and satisfactory criterial validity by positive correlations with measures of recovery attitudes and functioning, and negative correlations with measures of self-stigma, and psychotic and depressive symptoms.
CONCLUSIONS: The study results are discussed in the light of other studies examining the factor structure of the RAS. Overall, they support the use of the RAS-G as a means to promote recovery oriented services, policies, and research in German-speaking countries.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Measure; Psychosis; Reliability; Serious mental illness; Validity

Mesh:

Year:  2016        PMID: 28049083     DOI: 10.1016/j.eurpsy.2016.10.006

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  9 in total

Review 1.  The Relationship Between Clinical and Personal Recovery in Patients With Schizophrenia Spectrum Disorders: A Systematic Review and Meta-analysis.

Authors:  Robin Michael Van Eck; Thijs Jan Burger; Astrid Vellinga; Frederike Schirmbeck; Lieuwe de Haan
Journal:  Schizophr Bull       Date:  2018-04-06       Impact factor: 9.306

2.  Implementation, efficacy, costs and processes of inpatient equivalent home-treatment in German mental health care (AKtiV): protocol of a mixed-method, participatory, quasi-experimental trial.

Authors:  Johanna Baumgardt; Julian Schwarz; Sebastian Von Peter; Stefan Weinmann; Andreas Bechdolf; Konstantinos Nikolaidis; Martin Heinze; Johannes Hamann; Martin Holzke; Gerhard Längle; Janina Richter; Peter Brieger; Reinhold Kilian; Jürgen Timm; Constance Hirschmeier
Journal:  BMC Psychiatry       Date:  2021-03-30       Impact factor: 3.630

3.  Mental health specialist video consultations for patients with depression or anxiety disorders in primary care: protocol for a randomised controlled feasibility trial.

Authors:  Justus Tönnies; Mechthild Hartmann; Michel Wensing; Joachim Szecsenyi; Andrea Icks; Hans-Christoph Friederich; Markus W Haun
Journal:  BMJ Open       Date:  2019-09-04       Impact factor: 2.692

4.  Mental Health Specialist Video Consultations Versus Treatment-as-Usual for Patients With Depression or Anxiety Disorders in Primary Care: Randomized Controlled Feasibility Trial.

Authors:  Justus Tönnies; Mechthild Hartmann; Michel Wensing; Joachim Szecsenyi; Frank Peters-Klimm; Regina Brinster; Dorothea Weber; Markus Vomhof; Andrea Icks; Hans-Christoph Friederich; Markus W Haun
Journal:  JMIR Ment Health       Date:  2021-03-12

5.  Mental health specialist video consultations versus treatment as usual in patients with depression or anxiety disorders in primary care: study protocol for an individually randomised superiority trial (the PROVIDE-C trial).

Authors:  Markus W Haun; Justus Tönnies; Regina Krisam; Dorothea Kronsteiner; Michel Wensing; Joachim Szecsenyi; Markus Vomhof; Andrea Icks; Beate Wild; Mechthild Hartmann; Hans-Christoph Friederich
Journal:  Trials       Date:  2021-05-05       Impact factor: 2.279

6.  Validation of an 8-item Recovery Assessment Scale (RAS-8) for people with schizophrenia in China.

Authors:  Si-Jia He; Yan-Wen Fang; Zi-Xin Huang; Yu Yu
Journal:  Health Qual Life Outcomes       Date:  2021-04-13       Impact factor: 3.186

7.  Mental health specialist video consultations for patients with somatic symptom disorder in primary care: protocol for a randomised feasibility trial (the VISION trial).

Authors:  Markus W Haun; Justus Tönnies; Leike Graue; Mechthild Hartmann; Michel Wensing; Joachim Szecsenyi; Beate Wild; Hans-Christoph Friederich
Journal:  BMJ Open       Date:  2022-04-11       Impact factor: 2.692

8.  Validation of the 24-item recovery assessment scale-revised (RAS-R) in the Norwegian language and context: a multi-centre study.

Authors:  Eva Biringer; Marit Tjoflåt
Journal:  Health Qual Life Outcomes       Date:  2018-01-25       Impact factor: 3.186

9.  Attitudes towards disclosing a mental illness: impact on quality of life and recovery.

Authors:  Lea Mayer; Patrick W Corrigan; Daniela Eisheuer; Nathalie Oexle; Nicolas Rüsch
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2021-04-24       Impact factor: 4.328

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.